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Much of the mortality attributed to influenza virus is
due to secondary bacterial pneumonia, particularly
from Streptococcus pneumoniae. However, mecha-
nisms underlying this coinfection are incompletely
understood. We find that prior influenza infection en-
hances pneumococcal colonization of the murine
nasopharynx, which in turn promotes bacterial
spread to the lungs. Influenza accelerates bacterial
replication in vivo, and sialic acid, a major compo-
nent of airway glycoconjugates, is identified as the
host-derived metabolite that stimulates pneumo-
coccal proliferation. Influenza infection increases
sialic acid and sialylated mucin availability and
enhances desialylation of host glycoconjugates.
Pneumococcal genes for sialic acid catabolism are
required for influenza to promote bacterial growth.
Decreasing sialic acid availability in vivo by genetic
deletion of the major airway mucin Muc5ac or muco-
lytic treatment limits influenza-induced pneumo-
coccal replication. Our findings suggest that higher
rates of disease during coinfection could stem from
influenza-provided sialic acid, which increases pneu-
mococcal proliferation, colonization, and aspiration.
INTRODUCTION
Even before the discovery of its viral cause, bacterial infections
have been recognized as an important complication of influenza
(McCullers, 2006). Much of the mortality attributed to this virus
during both seasonal and pandemic influenza seasons is actually
from secondary bacterial pneumonia, particularly due to Strep-
tococcus pneumoniae, the pneumococcus (McCullers, 2006).
All pneumococcal disease begins with asymptomatic coloni-
zation of the nasopharynx (Bogaert et al., 2004). Though carriage
is the prerequisite to invasive disease, including pneumonia,
most studies of influenza-pneumococcal interaction have relied
on directly inoculating bacteria into the lung, bypassing this first,
conserved step in pathogenesis (McCullers, 2006; Metzger and
Sun, 2013). However, there is evidence that influenza predis-
poses the host to acquiring pneumococcal colonization (GrijalvaCet al., 2014). Pneumococcal colonization in adults and children is
temporally associated with viral upper respiratory tract (URT)
infections, including influenza, (Kim et al., 1996; Vu et al., 2011)
and experimental influenza infection leads to higher pneumo-
coccal loads in the human nasopharynx (Wadowsky et al.,
1995). Additionally, the URT is the initial site of replication for
both pneumococci and influenza (Bogaert et al., 2004; Matroso-
vich et al., 2004).
In addition to focusing on the lower respiratory tract, studies of
the interactions between influenza and pneumococci have his-
torically emphasized influenza-induced epithelial damage that
alters lung architecture and promotes bacterial adherence
(Metzger and Sun, 2013; Olitsky and Gates, 1921). More recent
studies have observed in vitro that influenza neuraminidase
can expose receptors for bacterial adherence by removing ter-
minal sialic acid residues from host glycoconjugates and in vivo
that neuraminidase inhibitors protect from postinfluenza pneu-
monia (McCullers, 2004; Peltola andMcCullers, 2004). However,
viral strains that do not cause pathologic changes in the epithe-
lium can still lead to secondary bacterial pneumonia in animal
models, implying that tissue damage is not necessary for influ-
enza to promote bacterial disease (Metzger and Sun, 2013).
Other work has focused on defects in antibacterial immunity
directed by prior viral infection. Influenza influences the immune
response to secondary bacterial challenge in murine models of
coinfection (McCullers, 2006; Metzger and Sun, 2013). Different
groups have demonstrated changes in neutrophil recruitment to
the lungs, alveolar macrophage function, and macrophage
recruitment to the nasopharynx during postinfluenza challenge
(Nakamura et al., 2011; Shahangian et al., 2009; Sun and
Metzger, 2008). These immune effects are general, but only a
small subset of opportunistic bacterial pathogens cause the
vast majority of postinfluenza pneumonia, and chief among
these is the pneumococcus (Klugman et al., 2009; McCullers,
2006; Metzger and Sun, 2013). The predominance of pneumo-
cocci in postinfluenza disease suggests that this bacterium is
particularly able to take advantage of the influenza-infected envi-
ronment. We hypothesized that influenza infection predisposes
the host to rapid pneumococcal growth in the nasopharynx by
providing a nutrient source for replicating bacteria.
Here, we show influenza promotes pneumococcal prolifera-
tion during colonization in a mouse model of coinfection, that
this rapid bacterial growth is dependent on acquisition of the
host metabolite sialic acid, that sialylated airway mucins
are required for this effect, and that both influenza andell Host & Microbe 16, 55–67, July 9, 2014 ª2014 Elsevier Inc. 55
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Sialic Acid Promotes Growth during Coinfectionpneumococcal neuraminidases contribute to the release of sialic
acid from host substrates in vivo.
RESULTS
Influenza Promotes Pneumococcal Colonization,
Growth, and Aspiration
To determine whether influenza infection could promote bacte-
rial colonization of the URT, mice were intranasally inoculated
with influenza A virus or PBS (mock). This procedure was carried
out using a small volume in unanesthetized mice to avoid direct
introduction into the lower respiratory tract. The x31 influenza
strain replicated efficiently in the URT, as measured by quantita-
tive RT-PCR (qRT-PCR) viral titers in nasal lavages, which
peaked at 3 days postinoculation (Figure 1A). This infection did
not cause weight loss or other signs of systemic disease (Fig-
ure 1B). Seven days after inoculation, we challenged the mice
with pneumococci 24 hr before obtaining nasal lavages to mea-
sure bacterial colonization density. Influenza infection promoted
>25-fold higher density of colonizing pneumococci with clinical
isolates of two different serotypes, 23F (strain P1121) and 4
(strain TIGR4) (Figure 1C).
To address whether this difference in colonization density was
due to influenza promoting increased retention of the bacterial
inoculum, we challenged mock- and influenza-infected mice
for <1 hr before measuring bacterial density in nasal lavages.
In contrast to observations at 24 hr postinoculation, there was
no difference in bacterial load 1 hr postchallenge, suggesting
that initial adherence to the epithelium was not responsible for
the effect of prior influenza infection on colonization (Figure 1D).
We next tested whether influenza promoted bacterial growth,
rather than or in addition to inhibiting antibacterial immunity in
the nasopharynx. To specifically measure bacterial replication
in vivo, we developed a flow cytometric assay using carboxy-
fluorescein diacetate succinimidyl ester (CFSE), a dye used to
track eukaryotic cell division. Each round of cell division yields
bacteria with less CFSE fluorescence, which we measured in
individual cells using flow cytometry (Parish, 1999). We validated
the assay in vitro and in vivo to demonstrate that only dividing
bacteria progressively lost CFSE fluorescence (Figure S1 avail-
able online). This assay was applied to influenza coinfection by
inoculating CFSE-labeled pneumococci into mice that had
been previously influenza or mock infected. Eight hours later,
we recovered the colonizing pneumococci in nasal lavages,
stained the lavage with capsule-type-specific antibody to distin-Figure 1. Influenza Promotes Pneumococcal Colonization, Growth, an
(A) Mice were infected with influenza for the indicated number of days, nasal lava
measure the relative expression of x31 viral nucleoprotein (NP).
(B) Mice given PBS (mock, open symbols) or influenza (closed symbols) were weig
(C) Mice were infected with influenza or PBS, followed 7 days later by intranasa
inoculation (hpi), nasal lavages were obtained and plated for quantitative culture
(D) Mice were inoculated with influenza or PBS, followed 7 days later by challen
quantitative culture (CFUs).
(E) After 7 days of mock (black line) or influenza (gray shaded) infection, mice w
obtained, fixed, and stained for pneumococcal capsule, and flow cytometry was
(F) The MFI of CFSE per bacterial cell was calculated for each condition and dis
(G) Mock- or influenza-infected mice were challenged 7 days later with WT pn
quantitative culture. Horizontal lines indicate median values, and data in (F) are r
0.001. All experiments were performed at least twice, with four to eleven mice p
Cguish pneumococci from other particles, and measured CFSE
fluorescence per cell. Pneumococci colonizing mice that had
been previously infected with influenza had substantially less
CFSE fluorescence per cell than did those colonizing mock-
treated mice (Figure 1E). To quantify this growth effect, we
measured the median fluorescence intensity (MFI) of CFSE per
bacterium in each condition. As replication occurred, the MFI
decreased and 1/MFI increased (Figure 1F). Additionally, we
calculated the division index, the number of divisions per cell
(Roederer, 2011). Bacteria colonizing influenza-infected mice
underwentmore divisions than those inmock-infectedmice (Fig-
ure 1F). Over 8 hr, influenza promoted 3.7-foldmore divisions per
bacterial cell compared to PBS treatment, an effect predicted to
increase bacterial numbers by 13-fold (23.7). This corresponded
to the 12.1-fold increase in colonization density actually
observed, a further validation for this assay and demonstrating
the importance of bacterial growth in mediating increased colo-
nization during coinfection.
Pneumonia generally begins with aspiration of upper airway
contents into the lungs, and clinical studies have noted that
pneumococcal pneumonia is associated with higher density of
concurrent colonizing pneumococci in the nasopharynx (Albrich
et al., 2012; Vu et al., 2011). We hypothesized that the increased
bacterial growth stimulated by influenza could increase the likeli-
hood of aspiration of pneumococci into the lungs. To test this
possibility, we measured bacterial loads in the bronchoalveolar
lavage fluid (BAL) of mock- and influenza-treated mice 24 hr
after establishing pneumococcal colonization of the URT. Influ-
enza-infected mice had a higher bacterial burden in the lower
respiratory tract compared to mock-treated mice (Figure 1G).
Colonization density in the URT correlated with bacterial load
in the BAL (Spearman correlation coefficient, r = 0.6, p < 0.05).
Influenza Increases Sialic Acid Availability in the
Nasopharynx
We next sought to determine the nutrient(s) influenza was
providing to colonizing pneumococci. Pneumococci have com-
plex growth requirements and can catabolize >30 different car-
bohydrates as carbon sources (Buckwalter and King, 2012). To
assess the availability of possible nutrient sources from inflam-
mation and epithelial damage following influenza infection, we
measured the total protein concentration of nasal lavages ob-
tained from mice 7 days after influenza or mock infection and
found no significant difference between these mice (Figure 2A).
We measured the total reducing sugar content of nasal lavagesd Aspiration
ges with RLT RNA lysis buffer were obtained, and qRT-PCR was performed to
hed daily for 7 days, and the percent change in weight from baseline graphed.
l inoculation with bacteria of the indicated serotype. After 24 hr postbacterial
of colonizing pneumococci.
ge with strain P1121. Within 1 hr, nasal lavages were obtained and plated for
ere inoculated with CFSE-labeled pneumococci for 8 hr. Nasal lavages were
performed to compare bacterial replication.
played as 1/MFI, or number of divisions per cell (division index).
eumococci for 24 hr. Bronchoalveolar lavages were obtained and plated for
epresented as mean ±SD. n.s., not significant; *, p < 0.05; **, p < 0.01; ***, p <
er group. See also Figure S1.
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Availability in the Nasopharynx
(A–D) Mice were intranasally inoculated with influ-
enza (closed bars) or mock (PBS, open bars) for
7 days, then nasal lavages were obtained to mea-
sure levels of protein (A), reducing sugars (B), and
sialic acid ([C] and [D]) in the lavages. Sialic acid
measurements were performed without (C) or with
(D) mild acid hydrolysis to measure free and total
sialic acid, respectively, in lavages from mice in-
fected with influenza for the indicated number of
days (dpi). Data are represented asmean ±SD. ND,
not detected (below the limit of detection, indi-
cated with a dotted line). n.s., not significant; **, p <
0.01. Experiments were performed at least twice,
with 3–14 mice per group. See also Figure S2.
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tween mock- and influenza-infected mice (Figure 2B). The tetra-
zolium assay can only measure reducing sugar, however (Jue
and Lipke, 1985). Sialic acid is a nonreducing sugar that is the
most common terminal, and therefore accessible, modification
on glycoconjugates in the airway (Angata and Varki, 2002). It is
released from cells and mucus after cleavage by influenza neur-
aminidase during viral replication (Peltola and McCullers, 2004).
Additionally, pneumococci express two to three neuraminidases
per strain that liberate sialic acid (Burnaugh et al., 2008). Sialic
acid can support pneumococcal growth in vitro as a sole carbon
source, and pneumococci express a sialic acid transporter,
SatABC, required for its utilization (Marion et al., 2011).
The amount of sialic acid freely accessible in lavage fluid was
below the limit of detection inmock-infectedmice but detectable
in all mice infected with influenza for 7 days (Figure 2C). To ac-
count for the total sialic acid available in lavage fluid, samples
were treated with exogenous neuraminidase (data not shown)
or mild acid hydrolysis to release all bound sialic acid from glyco-
conjugates (Nakano and Ozimek, 1999). Influenza infection was
associated with significantly more total sialic acid in the naso-
pharynx compared to mock infection (Figure 2D), as measured
by the thiobarbituric acid assay and validated by DMB-HPLC
detection (Figure S2).
Pneumococci Exploit Host Glycoconjugates for Growth
during Coinfection
After observing that influenza infection induced a selective in-
crease in sialic acid levels, we tested whether this increase
was responsible for the increased pneumococcal growth medi-
ated by influenza. We inoculated mock- and influenza-infected58 Cell Host & Microbe 16, 55–67, July 9, 2014 ª2014 Elsevier Inc.mice with pneumococci that could not
catabolize sialic acid (DsatABC or DnanA
DnanBDsatABC). The latter mutant also
lacks all neuraminidases present in the
parental strain, preventing release of sialic
acid and thereby limiting access to
additional sugars that underlie sialic acid
on host glycoconjugates (Burnaugh
et al., 2008). The locus containing these
five genes is shown in Figure 3A (Aziz
et al., 2008). After 8 hr, we measured bac-terial colonization. Neither mutant strain had a defect in early
colonization of mice in the absence of influenza. In contrast,
pneumococci unable to metabolize sialic acid no longer ex-
hibited increased colonization in the presence of influenza
(Figure 3B).
Next, we applied the CFSE assay to measure bacterial growth
and determined that the number of divisions per cell was lower
with both sialic acid mutant strains compared to wild-type (WT)
in the presence, but not absence, of influenza (Figure 3C).
Genetic correction of the mutation in sialic acid utilization
(DsatABC/satABC+) restored increased bacterial load in the
presence of influenza to WT levels (Figure 3D). To test whether
influenza could promote the outgrowth of sialic-acid-catabo-
lizing bacteria, mock- and influenza-infected mice were chal-
lenged with a mixed inoculum of sialic-acid-catabolizing and
DsatABC mutant pneumococci. One day later, the proportion
of sialic-acid-catabolizing bacteria colonizing the nasopharynx
had increased 10-fold in the presence of influenza (Figure 3E).
Sialylated Airway Mucins Are Required for Influenza-
Induced Pneumococcal Growth
Since pneumococci can grow on mucin glycoproteins as a sole
carbon source in vitro (Yesilkaya et al., 2008), we assessed the
availability of mucus, as seen by Alcian blue staining for acidic
mucopolysaccharides, in the URT. Influenza increased the
amount of mucus present in the nasopharyngeal lumen (Fig-
ure 4A). We next examined expression of Muc5ac, the major
airwaymucin secreted during inflammation and one that is highly
decorated by sialic acid residues (Koeppen et al., 2013; Rose
and Voynow, 2006). Influenza induced secretion of Muc5ac
onto the mucosal surface during influenza infection (Figure 4B).
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Figure 3. Pneumococci Exploit Host Glycoconjugates for Growth during Coinfection
(A) The genetic locus in strain P1121 containing the neuraminidase (nanA and nanB) and sialic acid transport (satABC) genes is displayed.
(B) Seven days after mock (open symbols) or influenza infection (closed symbols), mice were inoculated with CFSE-labeled pneumococci of the indicated
genotypes for 8 hr. Nasal lavages were obtained and plated for quantitative culture.
(C) Lavages were fixed and stained for pneumococcal capsule, and flow cytometry was performed to measure bacterial replication (division index).
(D) Mice were infected with influenza for 7 days, followed by 24 hr of colonization with the indicated bacterial strains. Nasal lavages were plated for quantitative
culture.
(E) Seven days after mock or influenza infection, mice were given a mixed inoculum of sialic-acid-catabolizing and DsatABC pneumococci. One day later, nasal
lavages were obtained and plated for quantitative culture. Colonies from the plated inoculum and the lavages were patched onto antibiotic-containing media to
determine the relative advantage in vivo of sialic acid catabolism and calculate competitive indices. CI > 1 indicates outcompetition of the streptomycin-resistant
DsatABC pneumococci and was defined as the ratio of WT/mutant bacteria in the output (nasal lavage) divided by the ratio of WT/mutant bacteria in the input
(inoculum). Data in (C) are represented as mean ±SD. Horizontal lines indicate median values. n.s., not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Experiments were performed at least twice, with 3–15 mice per group.
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Figure 4. Sialylated Airway Mucins Are Required for Influenza-Induced Pneumococcal Growth
(A) Mouse heads were obtained after 7 days of mock or influenza infection, fixed, decalcified, and sectioned. URT sections were stained with Alcian blue and
nuclear fast red. Scale bars, 50 mm.
(B) Nasal lavages were obtained from mice infected with influenza or PBS for 7 days and then analyzed by western blot for the presence of Muc5ac.
(legend continued on next page)
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URT that was maximal at 7 dpi (Figure 4C). These results corre-
lated with the availability of total sialic acid, which was also
maximal at 7 dpi (Figure 2D). To test whether mucins were a
major source of sialic acid during influenza infection, we first
examined Muc5ac/ mice. There was no defect in pneumo-
coccal colonization or growth inMuc5ac/mice in the absence
of influenza, but the influenza-mediated increases in bacterial
load (Figure 4D) and replication (Figure 4E) were attenuated in
mice that lack this airway mucin. These decreases in growth
and bacterial density in Muc5ac/ mice were not due to a
less robust influenza infection, as determined by viral titers
(data not shown). To further assess the role of mucins in pneu-
mococcal replication during coinfection, we intranasally treated
mock- and influenza-infected WT mice with the mucolytic agent
N-acetylcysteine daily until pneumococcal challenge. Mucolytic
treatment reduced bacterial load (Figure 4F) and growth
(Figure 4G), but only in influenza-infected mice. Both genetic
deletion and mucolytic treatment reduced total sialic acid in
the influenza-infected nasopharynx, confirming that sialylated
mucins are a host-derived source of sialic acid pneumococci
exploit during coinfection (Figure 4H).
Influenza and Bacterial Neuraminidases Desialylate
Host Substrates
We next examined whether viral and bacterial neuraminidases
released sialic acid from host sources for pneumococci to use
for growth. We qualitatively measured sialic acid release from
the epithelial surface by fluorescence microscopy using a fluo-
rescently labeled lectin from Erythrina cristagalli, which binds
to galactose residues that are exposed when sialic acid is
cleaved (Chang et al., 2012). After 7 days of influenza or mock
infection, URT sections from mouse heads were stained with
the E. cristagalli lectin. Influenza infection promoted increased
desialylation of the mucosal surface in the nasopharynx. Bacte-
rial neuraminidase desialylated host surfaces further, as there
was additional lectin binding in samples from mice given pneu-
mococci for 24 hr after 7 days of influenza. This effect was spe-
cific to the pneumococcal neuraminidases, as the epithelial
surface in influenza-infected mice colonized with neuramini-
dase-deficient (DnanADnanB) pneumococci had less lectin bind-
ing, and therefore less desialylation, than did those colonized
with WT pneumococci (Figure 5A). As a quantitative measure
of desialylation, we used flow cytometry to quantify desialylation
on infiltrating leukocytes (>80% neutrophils), which are abun-
dant in the influenza-infected airway and can be easily obtained
by nasal lavage (data not shown). This method confirmed the
pattern of desialylation observed with fluorescence microscopy
(Figure 5B). These findings indicated that both viral and bacterial(C) Nasal lavages with RLT RNA lysis buffer were obtained frommice influenza or
Muc5ac was measured.
(D) Mice of indicated genotype were mock or influenza infected for 7 days, followe
obtained and plated for quantitative culture.
(E) Lavages were also fixed and stained for pneumococcal capsule, and flow cy
(F and G) WTmice were infected with influenza or mock, followed by daily treatme
pneumococci were inoculated for 8 hr, then nasal lavages were obtained and us
(H) Total sialic acid content was measured by thiobarbituric acid assay on samp
median values. *, p < 0.05; **, p < 0.01. Experiments were performed at least tw
Cneuraminidases contribute to the desialylation in vivo of host
substrates during coinfection.
Sialic Acid Catabolism Contributes to Pneumococcal
Colonization in the Absence of Influenza
To assess the role of sialic acid catabolism during pneumo-
coccal colonization, we measured sialic acid in nasal lavages
from mice inoculated with pneumococci in the absence of influ-
enza infection. Total sialic acid increased over the duration of
colonization, though no free sialic acid was detectable (Fig-
ure 6A). Consistent with the slow increase in sialic acid during
colonization, we observed that WT pneumococci outcompeted
DsatABC and that this outcompetition increased over time, but
it was delayed compared to influenza coinfection (Figure 6B).
As with influenza infection, pneumococcal colonization induced
URT transcription of the sialylated mucin Muc5ac (Figure 6C).
Nutrient-Poor Conditions on the Human Mucosal
Surface Favor Growth of Sialic Acid Catabolizing
Pneumococci
To extend our findings on sialic acid catabolism to human sam-
ples, we competed bacterial strains for growth in vitro in human
nasal airway surface fluid (hNASF), the natural environment in
which pneumococci replicate. There was little competition be-
tween WT and DsatABC pneumococci when grown in nutrient
broth that contains glucose, (Figure 7A) an in-vitro-preferred
carbon source not found in airway secretions (Philips et al.,
2003). The competitive advantage due to sialic acid catabolism
increased 15-fold when pneumococci were grown in nutrient-
limited hNASF. In contrast, there was no significant advantage
for WT over the genetically corrected DsatABC/satABC+ strain
in growth in hNASF (Figure 7A). This effect correlated with the
higher levels of sialic acid found in hNASF compared to nutrient
broth (Figure 7B). These sialic acid levels could not be directly
compared to those found in murine nasal lavages, as the latter
are dilutions of the epithelial lining fluid. The total volume of up-
per airway surface fluid in an adult mouse has been estimated as
3 ml (Asahi et al., 2002). Assuming the 200 ml nasal lavage con-
tained the entire surface lining fluid, the lavages are at least a
1:67 dilution of that fluid. The 30 mM sialic acid concentration
measured, therefore, would correspond to >2 mM sialic acid
on the mucosal surface during coinfection, a concentration suf-
ficient to promote growth in vitro as a sole carbon source
(Figure 7C).
DISCUSSION
Influenza has long been associated with secondary bacterial
pneumonia, but how this viral infection primes the host for themock-infected for 7 days. qRT-PCR was performed, and relative expression of
d by inoculation with CFSE-labeled pneumococci for 8 hr. Nasal lavages were
tometry was performed to measure bacterial replication (division index).
nt for 7 days with vehicle (PBS) or 0.5 M N-acetylcysteine (NAc). CFSE-labeled
ed for quantitative culture (F) and flow cytometric analysis of cell division (G).
les from (D)–(G). Data are represented as mean ±SD. Horizontal lines indicate
ice, with 3–13 mice per group.
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Figure 5. Influenza and Bacterial Neuraminidases Desialylate Host Substrates
(A and B) Mouse heads (A) and nasal lavages (B) were obtained from separate mice after 7 days of influenza or mock infection, followed by 24 hr of colonization
withWT orDnanADnanB pneumococci, or PBS. Heads were fixed, decalcified, and sectioned. URT sections were stained with DAPI and FITC-labeled lectin from
E. cristagalli that binds galactose residues exposedwhen sialic acid is removed. All images were takenwith the same optical settings. Scale bars, 50 mm. Lavages
were stained with FITC-labeled E. cristagalli lectin. Flow cytometry was performed by gating on neutrophils and comparing desialylation. Experiments were
performed at least twice, with three to ten mice per group.
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derstood. Here, we demonstrated that influenza infection predis-
posed mice to increased pneumococcal colonization in the
nasopharynx and that faster bacterial replication contributed to
this effect. This influenza-mediated growth led to increased aspi-
ration into the lower respiratory tract and was dependent on
pneumococcal catabolism of the host sugar sialic acid and
host expression of sialylated airway mucins, with both viral and
bacterial neuraminidases contributing to the desialylation of
host cells in vivo. Sialic acid utilization was important even during
pneumococcal colonization in the absence of influenza, but to a
lesser extent, consistent with the lower levels of sialic acid pre-
sent without influenza infection.
In this study, we challenged mice with pneumococci after
7 days of influenza infection in the URT. At 7 days postinfection,
influenza viral titers are declining from a peak reached at 3 to 5
dpi, the same time at which sialic acid levels and sialylatedmucin
expression in the nasopharynx are increasing. Previous animal
studies have indicated this time point correlates with the peak
of susceptibility to pneumonia when pneumococci are intro-
duced directly into the lower respiratory tract (McCullers and
Rehg, 2002; Sun and Metzger, 2008). The window of62 Cell Host & Microbe 16, 55–67, July 9, 2014 ª2014 Elsevier Inc.susceptibility to pneumococcal pneumonia is also 7 to 10 days
following influenza infection in humans (Shrestha et al., 2013).
Correlations between URT pneumococcal colonization den-
sity and pneumonia have been observed in human patients,
but it has not been clear whether higher bacterial burdens in
the upper airway precede pneumonia or are an effect of lower
airway disease (Albrich et al., 2012). We found that influenza,
by promoting higher bacterial load in the nasopharynx, led to
increased aspiration of pneumococci into the lower respiratory
tract, experimentally demonstrating that higher levels of coloni-
zation can increase a key step in the early pathogenesis of
pneumonia.
Previous studies of the interaction between influenza and
pneumococci have focused on epithelial damage or immune
dysfunction induced by the viral infection, promoting increased
bacterial adherence or decreased bacterial clearance, respec-
tively (McCullers, 2006; Metzger and Sun, 2013). We found no
difference in initial adherence of the bacterial inoculum after
influenza infection, and further found no increases in total protein
or glycan content, suggesting this infection did not cause exten-
sive tissue damage. Using the dilution of CFSE dye, we demon-
strated a role for bacterial replication in mediating increased
AC
B Figure 6. Sialic Acid Catabolism Contrib-
utes to Pneumococcal Colonization in the
Absence of Influenza
(A) Mice were colonized with pneumococci for the
indicated number of days. Sialic acid concentra-
tions in lavages were measured by thiobarbituric
acid assay, with or without acid hydrolysis to
measure total (solid bars) and free sialic acid (open
bars), respectively.
(B) WT and DsatABC pneumococci were
competed in vivo by colonizing naive mice with
mixed inocula. Nasal lavages were plated for
quantitative culture and colonies from the inocula
and lavages patched onto antibiotic-selective
media to determine the relative advantage of sialic
acid catabolism in vivo and calculate competitive
indices. CI > 1 indicates WT outcompeted
DsatABC pneumococci.
(C)Nasal lavageswereobtainedwithRLTRNA lysis
buffer from mice colonized with pneumococci for
the indicated number of days. qRT-PCR was per-
formed to measure relative expression ofMuc5ac.
Data are represented as mean ±SD. ND, not de-
tected (below the limit of detection, indicatedwith a
dotted line); *, p < 0.05. Experiments were per-
formed at least twice, with 3–20 mice per group.
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between influenza and bacteria have measured bacterial
numbers, the sum of bacterial growth and clearance. We
measured both bacterial numbers and bacterial growth, allowing
us to separate the contribution of bacterial growth from that of
immune evasion. Our data are consistent with previous studies
demonstrating the importance of viral neuraminidase for the
interaction of influenza and pneumococci (Peltola and McCul-
lers, 2004; Peltola et al., 2005). Those studies emphasized neur-
aminidase removing sialic acid to expose underlying receptors
for pneumococci, but the same enzymatic activity would also
release free sialic acid into the nasopharynx for pneumococci
to utilize.
Our work has implications for the therapeutic use of neura-
minidase inhibitors. Most clinical studies of neuraminidase
inhibitor efficacy have focused on early treatment, (Herna´n
and Lipsitch, 2011; Hsu et al., 2012), but experiments in mice
demonstrated survival benefits to neuraminidase inhibitor treat-
ment during coinfection even at later time points when there
was no effect on viral replication (McCullers, 2004). Our results
may provide a mechanistic understanding of this effect, as
inhibiting viral neuraminidase may limit sialic acid release
even after the peak in viral replication. Additional studies on
the effect of late neuraminidase inhibitor treatment on com-
plications related to bacterial density, such as pneumonia,
could be warranted. Bacterial neuraminidases, including pneu-
mococcal NanA and NanB, are not inhibited by clinically
used neuraminidase inhibitors at concentrations reached
in vivo (Nishikawa et al., 2012). Broader neuraminidase inhibi-Cell Host & Microbe 16,tors that can prevent bacterial acquisi-
tion of sialic acid, and underlying sugars
may be an important, unexplored thera-
peutic strategy.We observed desialylation of the mucosal surface and leuko-
cytes during influenza infection, exacerbated by coinfection with
neuraminidase-expressing pneumococci. We found that tran-
scription ofMuc5ac was upregulated in the nasopharynx during
influenza infection as part of the inflammatory response, consis-
tent with a previous report in the lungs of influenza-infected mice
(Barbier et al., 2012). We also found that mucus and Muc5ac
secretion increased during influenza infection and that reducing
mucins by genetic knockout ofMuc5ac, or solubilizing mucus by
N-acetylcysteine treatment, decreased influenza-induced pneu-
mococcal growth. Mucins are 50%–90% glycan by mass and
are heavily sialylated, particularly at the terminal, most-acces-
sible ends of sugar chains (Angata and Varki, 2002; Rose and
Voynow, 2006). The epithelial surface is also heavily sialylated
and could serve as an additional source of sialic acid during influ-
enza infection (Lewis and Lewis, 2012). The commensal flora of
the nasopharynx could also provide sialic acid (Shakhnovich
et al., 2002).
Sialic acid is both necessary and sufficient for pneumococcal
colonization in mice (Marion et al., 2011; Trappetti et al., 2009).
We noted a competitive disadvantage in vivo that increased
over 7 days of colonization for pneumococci that lack the sialic
acid transporter SatABC, consistent with previous work
showing a defect in colonization at 5 days postinoculation
(Marion et al., 2011). Increased nasal secretions, reflecting
greater sialylated mucin production, have been associated
with higher density of pneumococcal colonization in children
(Rodrigues et al., 2013). Exogenous sialic acid, but not other
amino sugars, has been shown to increase colonization density55–67, July 9, 2014 ª2014 Elsevier Inc. 63
AC
B Figure 7. Nutrient-Poor Conditions on the
Human Mucosal Surface Favor Growth of
Sialic-Acid-Catabolizing Pneumococci
(A) Bacteria of the indicated genotypes were
grown for 8 hr in mixed inocula in tryptic soy
nutrient broth or in nutrient-limited hNASF. Ali-
quots were plated at the beginning and end of the
growth period, and colonies patched onto antibi-
otic-selective media to determine the relative
advantage of sialic acid catabolism in vivo and
calculate competitive indices. CI > 1 indicates WT
outcompeted the indicated mutant strain.
(B) Total sialic acid in the growth media used in (A)
was measured by thiobarbituric acid assay after
acid hydrolysis.
(C) WT (solid bars) and DsatABC (open bars)
pneumococci were grown for 24 hr in chemically
defined medium with the indicated concentrations
of sialic acid as the sole carbon source. Data show
fold-growth compared to inoculum. Data are rep-
resented as mean ±SD. n.s., not significant; *, p <
0.05; **, p < 0.01; ***, p < 0.001. Experiments were
performed at least twice.
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mote pneumococcal growth as a sole carbon source (Marion
et al., 2011). The amount of nasopharyngeal sialic acid we
measured during influenza infection is likely to be an underes-
timate, as it does not include sialic acid still bound to epithelial
cells that would not be removed by nasal lavage. Sialic acid
release by viral and bacterial neuraminidases also exposes un-
derlying sugars, such as galactose and N-acetylglucosamine,
that can be liberated by the sequential activity of pneumo-
coccal exoglycosidases to serve as additional carbon sources
(Burnaugh et al., 2008; King et al., 2006). This effect could
explain why pneumococci that could not cleave or catabolize
sialic acid (DnanADnanBDsatABC) had a stronger defect in
influenza-mediated growth compared to those that could not
catabolize sialic acid (DsatABC). The viral neuraminidase could
also complement mutations in the pneumococcal neuramini-
dases. Free sialic acid only accumulated enough to be de-
tected after 7 days of influenza infection, even though viral
titers peaked earlier. This time point, however, represented
the peak of sialylated mucin availability. Our results suggest
that the combination of increased mucin availability and neur-64 Cell Host & Microbe 16, 55–67, July 9, 2014 ª2014 Elsevier Inc.aminidase activity is required for pro-
viding sufficient amounts of sialic acid.
Obtaining a source of carbon is neces-
sary for bacterial growth in any en-
vironment, but how this occurs during
colonization of the nutrient-poor mucosal
surface has been unclear (Buckwalter and
King, 2012). Free sugar is particularly
limited in the nasopharynx, the pneumo-
coccal niche, unlike in the intestines or
oral cavity (Philips et al., 2003). In the
gut, sialic acid released by the sialidase
of one bacterial species can promote
sialic acid catabolism-dependent growth
of another (Ng et al., 2013). Carbon acqui-sition is especially important for the pneumococcus, which de-
votes more of its genome to sugar transporters than any other
sequenced bacterium (Tettelin et al., 2001). This diversity implies
that pneumococci may encounter different host sugars in abun-
dance in distinct microenvironments; infection with neuramini-
dase-expressing viruses such as influenza could provide one
such microenvironment. Pneumococci are not the only bacteria
that can use sialic acid. Interestingly, the other prominent path-
ogens in secondary bacterial pneumonia following influenza,
Staphylococcus aureus and Haemophilus influenzae, can also
catabolize this host sugar (Olson et al., 2013; Vimr et al., 2000).
Sialic acid utilization could also contribute to other common bac-
terial complications following influenza infection, such as acute
otitis media (McCullers, 2006).
EXPERIMENTAL PROCEDURES
Mice
Six- to eight-week-old C57Bl/6 mice were obtained from Jackson Laboratory.
Muc5ac/ mice on a C57Bl/6 background were previously described (Has-
nain et al., 2011). Procedures were carried out according to an animal protocol
approved by the University of Pennsylvania IACUC.
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Mice were intranasally inoculated with 2 3 104 TCID50 of influenza A virus,
strain HKx31 (H3N2 from A/Hong Kong/1/1968 with the backbone of PR8
virus), diluted into 10 ml PBS.
Bacterial Strains and Colonization
Pneumococcal strains included TIGR4 (Tettelin et al., 2001) and P1121,
(McCool et al., 2002) clinical isolates of capsule types 4 and 23F, respectively.
Mutants of P1121 in the sialic acid transporter (satABC) were previously made
using the Janus cassette to create unmarked and correct mutations (Marion
et al., 2011). Mutants in the neuraminidase genes nanA and nanB were con-
structed as described previously by introducing antibiotic resistance cassettes
(King et al., 2004). Pneumococci were grown in tryptic soy (TS) nutrient broth at
37C until mid-log phase. For mouse colonization, 107 CFU bacteria were
inoculated intranasally in a volume of 10 ml. Mice were sacrificed, and nasal la-
vages obtained with 200 ml PBS. Lavages were plated on TS agar supple-
mented with catalase (5,000 U/plate) (Worthington Biochemical) and
5 mg/mL neomycin for quantitative culture in 5% CO2. TS agar was supple-
mented with 200 mg/ml streptomycin to distinguish DsatABC pneumococci
from WT. For bronchoalveolar lavage, 1 ml PBS was instilled into the lungs in-
tratracheally, withdrawn with a syringe, and used for quantitative culture.
CFSE Staining
Bacteria were resuspended in 1 ml PBS with 1% catalase and 10 mM carboxy-
fluorescein diacetate succinimidyl diester (Molecular Probes). Reactions were
incubated at 37C for 25 min and then washed three times in PBS. Mice were
inoculated with CFSE-labeled pneumococci. After 8 hr, mice were sacrificed
and nasal lavages obtained and then prepared for flow cytometry.
Flow Cytometry
For the in vivo CFSE assay, nasal lavages were obtained frommice inoculated
with CFSE-labeled pneumococci. Samples were fixed and stained with typing
serum specific to the capsule type used (Statens Serum Institut), followed
by AF647-labeled secondary antibody to rabbit IgG, then analyzed by flow
cytometry. For measurement of desialylation, nasal lavages were stained
with FITC-labeled lectin from Erythrina cristagalli (Vector Labs) and antibodies
to identify neutrophils: anti-Ly6G (clone 1A8) and anti-CD11b. Flow cytometry
was conducted using FACS Calibur and FACS Canto instruments (Becton
Dickinson) and analyzed using FlowJo software (Tree Star).
Protein, Reducing Sugar, and Sialic Acid Measurements
Protein wasmeasured by bicinchonic acid assay (Pierce). Reducing sugar was
measured by tetrazolium blue assay (Jue and Lipke, 1985). Samples were
diluted 1:100 in 0.1% tetrazolium blue, 0.05 M NaOH, and 0.5 M potassium
sodium tartrate. Samples were boiled for 10 min, and absorbance was
measured at 655 nm. Sialic acid was measured by thiobarbituric acid assay
(Nakano and Ozimek, 1999; Skoza and Mohos, 1976). To measure total sialic
acid, samples were first incubated with 0.1 M H2SO4 for 30 min at 80
C. All
samples were then incubated with 25 mM periodic acid/62.5 mM H2SO4 for
30 min at 37C, followed by boiling in 2% sodium arsenite/0.5 M HCl and
6% thiobarbituric acid for 10 min. Absorbance was measured at 550 nm and
compared to a standard curve to calculate concentrations in lavage fluid.
The specificity of this assay was confirmed by using exogenous neuramini-
dase instead of acid hydrolysis to enzymatically release sialic acid.
qRT-PCR
RNA was harvested from the URT epithelium by lavage with RLT buffer
(QIAGEN) with 1:100 b-mercaptoethanol. RNA was isolated with the RNeasy
kit (QIAGEN), and cDNA was reverse transcribed with the High-Capacity
cDNA Reverse Transcription kit (Applied Biosystems). Reactions were carried
out with Sybr Green reagents (Applied Biosystems) with 10 ng cDNA and
0.5 mM primers. Comparisons were made between conditions by the DDCT
method. Primer sequences are in Supplemental Experimental Procedures.
Western Blot
Proteins in nasal lavageswere separated by SDS-PAGEon a 10%Tris gel (Bio-
Rad) and transferred onto PVDF membrane. Muc5ac was detected by poly-Cclonal antibody (Santa Cruz Biotechnology) and rabbit anti-goat secondary
antibody conjugated to alkaline phosphatase (Sigma).
Microscopy
Tissue sections of the URT were obtained as previously described (Nelson
et al., 2007). Staining and microscopy was performed as described, modified
by blocking in 1% gelatin in PBS when using E. cristagalli lectin.
Growth in Human Nasal Airway Surface Fluid
Human nasal airway surface fluid was isolated as previously described (Gould
and Weiser, 2001). Pneumococci were grown to log phase in TS nutrient broth
and diluted to a concentration of 104 CFU/mL in both hNASF and TS. Reac-
tions were supplemented 1:100 with catalase and incubated at 37C in 5%
CO2 for 8 hr. Samples were plated for quantitative culture at the start and
end of the growth period, and colonies were patched onto antibiotic selective
media to calculate competitive indices. Pneumococci were grown in chemi-
cally defined medium as previously described, (Kloosterman et al., 2006)
with sialic acid in place of glucose.
Statistical Analysis
Prism (Graphpad) was used for statistical analysis. Comparisons were made
by Mann-Whitney U test for colonization (CFU) data and by Student’s t test
for all other data. For multiple comparisons, we used Kruskal-Wallis with
Dunn’s post hoc test or 1-way ANOVA with Newman-Keuls post hoc test,
respectively.
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